Minkyung (Min) Song, Ph.D.
Dr. Song fosters, manages, oversees and analyzes the NCI portfolio on multidisciplinary, translational and clinical research grants and cooperative agreements for:
- Clinical trials of chemotherapy, immunotherapy, cellular therapy, gene therapy, radiation therapy, surgery, or their combinations, and associated correlative studies;
- Discovery and development of new or improved anti-tumor agents; and
- Development and validation of clinical tools for monitoring responses to therapies, acquired resistance and recurrence of cancer.
Dr. Song is the NCI Program Contact for PAR-15-286 (X02) and PAR-15-287 (U01) to support extramural-intramural collaborative research at the NIH Clinical Center. She has participated in trans-NIH activities by representing the NCI for: the Rigor and Reproducibility Focus Group; the Working Group on Core Efficiency and Sustainability; the Roadmap/Common Fund Molecular Libraries Probe Production Centers Network Project Team; the Clinical and Translational Science Awards Consortium Translational Key Function Committee; and the Pharmacogenomics Research Network. She has co-chaired the NIH Translational Research Interest Group and Committees as well.
Dr. Song has received various Awards and Certificates, including the NIH Merit Award, the NIH Director’s Award, and Certificate for completing the NIH Senior Leadership Program. As an invited speaker, Dr. Song has presented and discussed topics related to the NIH Extramural Research Program at numerous international scientific meetings. She has participated in mentoring junior biomedical scientists and under-represented scientists as well.
Dr. Song received her Ph.D. degree in Biochemistry and Molecular Biology from the University of Minnesota Medical School in 1983. She was a Visiting Post-doctoral Fellow in the NCI Intramural Research Program for 3 years and a Senior Staff Fellow in the National Institute of Diabetes and Digestive and Kidney Diseases for 2.5 years. She co-authored ten articles published in peer-reviewed scientific journals between 1983 and 1989. Then, Dr. Song was an Interdisciplinary Regulatory Review Scientist in the Food and Drug Administration for 9 years before joining the NCI Extramural Research Program in 1997 as a Program Director in the Division of Cancer Treatment and Diagnosis.
About the Branch Chief
Vikram Devgan, Ph.D., MBA. joined the National Cancer Institute in 2016 as a Chief of Clinical Grants and Contracts Branch of the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis. From 2006 to 2016, Dr. Devgan held positions of increasing responsibilities with QIAGEN Inc., rising to Head of the Center of Excellence for Biological Research Content. More…